small molecule

ALCLOMETASONE DIPROPIONATE

ALCLOMETASONE DIPROPIONATE

Loss of exclusivityloss of exclusivity
CompanySUN PHARMA CANADA INC

Drug detail

Brand nameALCLOMETASONE DIPROPIONATE
Active ingredientALCLOMETASONE DIPROPIONATE
Strength0.05%
Dosage formCREAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalSeptember 2005
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ALCLOMETASONE DIPROPIONATE patent cliff — loss of exclusivity — | CliffBio